TEVA-FULVESTRANT INJECTION
Active Ingredient: FULVESTRANT
Product Overview
About TEVA-FULVESTRANT INJECTION
TEVA-FULVESTRANT INJECTION is a prescription medication containing the active ingredient Fulvestrant. It is used in the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following prior therapy.
Key Benefits & Uses
- Treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following prior therapy.
- Reduction in the size of tumors in the breast and other parts of the body.
- Delay in the progression of the disease.
Active Ingredient & Action
Fulvestrant is a selective estrogen receptor degrader (SERD) that works by binding to the estrogen receptor, promoting its degradation, and thereby reducing the levels of estrogen in the body. This action helps to slow down the growth of cancer cells that are fueled by estrogen.
Important Notes
TEVA-FULVESTRANT INJECTION should be administered by a healthcare professional. Patients should be informed about the potential risks and benefits of the medication and should be closely monitored for any signs of adverse reactions. The medication should be used under the guidance of a qualified healthcare professional.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.